Currently out of the existing stock ratings of Douglas Miehm, 18 are a HOLD (40%), 27 are a BUY (60%).

Douglas Miehm

Work Performance Price Targets & Ratings Chart

Analyst Douglas Miehm, currently employed at RBC, carries an average stock price target met ratio of 59.72% that have a potential upside of 38.76% achieved within 146 days.

Douglas Miehm’s has documented 90 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BHC, Bausch Health Companies at 30-Jan-2025.

Wall Street Analyst Douglas Miehm

Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for BHC (BAUSCH HEALTH COMPANIES) at 5/5/2023. The price target of $8 was fulfilled within 13 days with a profit of $2.17 (37.22%) receiving and performance score of 28.63.

Average potential price target upside

AUPH Aurinia Pharmaceuticals BHC Bausch Health Companies BLCO Bausch + Lomb Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$5.21 (66.88%)

$13

5 months 9 days ago
(06-Sep-2024)

10/22 (45.45%)

$5.74 (79.06%)

579

Hold

$6

$-1.79 (-22.98%)

$26

9 months 13 days ago
(02-May-2024)

3/3 (100%)

$0.83 (16.05%)

398

Buy

$8

$0.21 (2.70%)

$11

11 months 30 days ago
(16-Feb-2024)

8/12 (66.67%)

$2.15 (36.75%)

152

Hold

$13

2 years 3 months 11 days ago
(04-Nov-2022)

5/9 (55.56%)

$4.73 (57.19%)

203

Buy

$12

$4.21 (54.04%)

$22

2 years 3 months 11 days ago
(04-Nov-2022)

1/4 (25%)

$6.85 (133.01%)

266

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Douglas Miehm is most bullish on?

Potential upside of $5.59 has been obtained for BLCO (BAUSCH + LOMB CORP)

Which stock is Douglas Miehm is most reserved on?

Potential downside of $3.84 has been obtained for BHC (BAUSCH HEALTH COMPANIES)

What Year was the first public recommendation made by Douglas Miehm?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?